申请人:SURLERAUX Dominique Louis Nestor Ghislain
公开号:US20100029632A1
公开(公告)日:2010-02-04
The present invention concerns the compounds having the formula
N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R
1
and R
8
each are H, optionally substituted C
1-6
alkyl, C
2-6
alkenyl, C
3-7
cycloalkyl, aryl, Het
1
, Het
2
; R
1
may also be a radical of formula (R
11a
R
11b
)NC(R
10a
R
10b
)CR
9
—; t is 0, 1 or 2; R
2
is H or C
1-6
alkyl; L is —C(═O)—, —O—C(═O)—, —NR
8
—C(═O)—, —O—C
1-6
alkanediyl-C(═O)—, —NR
8
—C
1-6
alkanediyl-C(═O)—, —S(═O)
2
—, —O—S(═O)
2
—, —NR
8
—S(═O)
2
; R
3
is C
1-6
alkyl, aryl, C
3-7
cycloalkyl, C
3-7
cycloalkylC
1-4
alkyl, or arylC
1-4
alkyl; R
4
is H, C
1-4
alkylOC(═O), carboxyl, aminoC(═O), mono- or di(C
1-4
alkyl)aminoC(═O), C
3-7
cycloalkyl, C
2-6
alkenyl, C
2-6
alkynyl or optionally substituted C
1-6
alkyl; R
5
and R
6
are H or C
1-6
alkyl. It further relates to their use as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. It also concerns combinations thereof with another anti-retroviral agent, and to their use in assays as reference compounds or as reagents.
本发明涉及具有以下公式的化合物:N-氧化物、盐、立体异构体、混合物、前药、酯及其代谢物,其中R1和R8分别为H、可选取代的C1-6烷基、C2-6烯基、C3-7环烷基、芳基、Het1、Het2;R1还可以是公式(R11aR11b)NC(R10aR10b)CR9—的基团;t为0、1或2;R2为H或C1-6烷基;L为—C(═O)—、—O—C(═O)—、—NR8—C(═O)—、—O—C1-6烷二基-C(═O)—、—NR8—C1-6烷二基-C(═O)—、—S(═O)2—、—O—S(═O)2—、—NR8—S(═O)2;R3为C1-6烷基、芳基、C3-7环烷基、C3-7环烷基C1-4烷基或芳基C1-4烷基;R4为H、C1-4烷基OC(═O)、羧基、氨基C(═O)、单烷基或二烷基氨基C(═O)、C3-7环烷基、C2-6烯基、C2-6炔基或可选取代的C1-6烷基;R5和R6为H或C1-6烷基。本发明还涉及它们作为广谱HIV蛋白酶抑制剂的用途,以及它们的制备方法、包含它们的制药组合物和诊断试剂盒。它还涉及与其他抗逆转录病毒药物的组合,以及它们作为参考化合物或试剂在检测中的使用。